CSL Ltd (CSLLY)
91.71
-1.20
(-1.29%)
USD |
OTCM |
Nov 14, 16:00
CSL Enterprise Value: 99.71B for Nov. 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 14, 2024 | 99.71B |
| November 13, 2024 | 100.88B |
| November 12, 2024 | 100.87B |
| November 11, 2024 | 102.42B |
| November 08, 2024 | 101.45B |
| November 07, 2024 | 102.84B |
| November 06, 2024 | 101.85B |
| November 05, 2024 | 102.58B |
| November 04, 2024 | 101.72B |
| November 01, 2024 | 100.88B |
| October 31, 2024 | 101.70B |
| October 30, 2024 | 102.85B |
| October 29, 2024 | 103.72B |
| October 28, 2024 | 104.26B |
| October 25, 2024 | 105.18B |
| October 24, 2024 | 105.74B |
| October 23, 2024 | 104.91B |
| October 22, 2024 | 106.99B |
| October 21, 2024 | 108.58B |
| October 18, 2024 | 108.83B |
| October 17, 2024 | 108.42B |
| October 16, 2024 | 107.93B |
| October 15, 2024 | 108.27B |
| October 14, 2024 | 108.39B |
| October 11, 2024 | 107.93B |
| Date | Value |
|---|---|
| October 10, 2024 | 106.94B |
| October 09, 2024 | 107.08B |
| October 08, 2024 | 106.57B |
| October 07, 2024 | 105.40B |
| October 04, 2024 | 106.62B |
| October 03, 2024 | 106.71B |
| October 02, 2024 | 106.93B |
| October 01, 2024 | 107.30B |
| September 30, 2024 | 106.57B |
| September 27, 2024 | 106.84B |
| September 26, 2024 | 108.34B |
| September 25, 2024 | 106.27B |
| September 24, 2024 | 107.19B |
| September 23, 2024 | 107.38B |
| September 20, 2024 | 107.33B |
| September 19, 2024 | 108.47B |
| September 18, 2024 | 107.76B |
| September 17, 2024 | 108.33B |
| September 16, 2024 | 108.32B |
| September 13, 2024 | 108.61B |
| September 12, 2024 | 109.60B |
| September 11, 2024 | 108.57B |
| September 10, 2024 | 108.26B |
| September 09, 2024 | 108.84B |
| September 06, 2024 | 108.01B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
76.76B
Minimum
Mar 20 2020
118.27B
Maximum
Feb 03 2023
99.20B
Average
99.58B
Median
Enterprise Value Benchmarks
| Alterity Therapeutics Ltd | -- |
| Kazia Therapeutics Ltd | -- |
| Immutep Ltd | -- |
| Opthea Ltd | 489.22M |
| Mesoblast Ltd | -- |
Enterprise Value Related Metrics
| Earnings Yield | 2.97% |
| Operating Earnings Yield | 3.11% |
| Normalized Earnings Yield | 2.971 |